Skip to Content

Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

Health Highlights: May 7, 2021

U.S. Likely to Achieve July 4 COVID-19 Vaccination Target, But Challenges Remain It's likely that the United States will achieve President Joe Biden's target...

How Summer Camps Can Shield Your Kids from Allergies, Asthma & COVID

SUNDAY, May 9, 2021 -- As kids get ready for summer camp, parents might be fretting about exposure to COVID-19, but a doctors' group says they also need to...

Could Your Child Have a Heart Defect? Know the Warning Signs

SATURDAY, May 8, 2021 -- Heart defects are often – but not always – detected at birth, so it's important to pay attention when a child gets dizzy, passes out or...

Physician's Briefing Weekly Coronavirus Roundup

Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of May 3 to 7, 2021....

Poll Finds Many Parents Hesitant to Get Younger Children Vaccinated

FRIDAY, May 7, 2021 -- As U.S. health officials prepare to authorize the Pfizer COVID-19 vaccine for emergency use in younger children, a new poll shows that...

Low Bone Mineral Density Prognostic for Atherosclerotic CVD

FRIDAY, May 7, 2021 -- Bone mineral density (BMD) has independent prognostic value for predicting atherosclerotic cardiovascular disease (ASCVD) in women,...

U.S. Likely to Achieve July 4 COVID-19 Vaccination Target, but Challenges Remain

FRIDAY, May 7, 2021 -- It is likely that the United States will achieve President Joe Biden's target of having at least one dose of a COVID-19 vaccine into the...

Many Oncology Patients Are Lonely During COVID-19

FRIDAY, May 7, 2021 -- More than half of oncology patients are experiencing loneliness during the COVID-19 pandemic, and they report higher symptom severity...

Lots of Sugary Drinks Doubles Younger Women's Colon Cancer Risk: Study

FRIDAY, May 7, 2021 -- Rates of colon cancer among young Americans are on the rise, and a new study suggests that drinking too many sugary beverages may be to...

AHA News: How Social Isolation Can Harm Health as You Age – and How to Prevent It

FRIDAY, May 7, 2021 (American Heart Association News) -- Barbara Stopfer hasn't had much of a social life since her husband died six years ago. She stopped...

Clearside Biomedical Announces Resubmission of New Drug Application for Xipere for Treatment of Macular Edema Associated with Uveitis

ALPHARETTA, Ga., May 03, 2021 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company dedicated to developing and delivering...

Chiesi Global Rare Diseases Announces FDA Approval of Ferriprox (deferiprone) for Treatment of Transfusional Iron Overload due to Sickle Cell Disease

May 1, 2021 Approval is based on demonstrated reduction in liver iron concentration Expanded indications for patients with sickle cell disease or other...

FDA Approves Kloxxado (naloxone hydrochloride) Nasal Spray for Emergency Treatment of Opioid Overdose

LONDON, April 30, 2021 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces the approval of Kloxxado...

Farxiga Approved in the US for the Treatment of Chronic Kidney Disease in Patients at Risk of Progression With and Without Type-2 Diabetes

30 April 2021 Approval is the most significant advancement in the treatment of chronic kidney disease in more than 20 years In DAPA-CKD Phase III trial,...

Takeda Announces U.S. FDA Grants Priority Review for New Drug Application for Mobocertinib (TAK-788) as a Treatment for EGFR Exon20 Insertion+ Metastatic Non-Small Cell Lung Cancer

CAMBRIDGE, Mass. & OSAKA, Japan--(BUSINESS WIRE) April 27, 2021-- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today...

Reata Announces FDA Accepted for Filing the NDA for Bardoxolone for the Treatment of Patients With Chronic Kidney Disease Caused by Alport Syndrome

PLANO, Texas, April 26, 2021 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the “Company,” or...

Axsome Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for AXS-05 for Treatment of Major Depressive Disorder

NEW YORK, April 26, 2021 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing novel therapies for the...

FDA Approves Zynlonta (loncastuximab tesirine-lpyl) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma

LAUSANNE, Switzerland--(BUSINESS WIRE) APRIL 23, 2021 -- ADC Therapeutics SA (NYSE: ADCT) today announced that the U.S. Food and Drug Administration (FDA) has...

FDA Approves Jemperli (dostarlimab-gxly) for Women with Recurrent or Advanced dMMR Endometrial Cancer

London UK 22 April 2021 -- GlaxoSmithKline today announced that the US Food and Drug Administration (FDA) has approved Jemperli (dostarlimab-gxly), a...

Genmab and Seagen Announce U.S. FDA Filing Acceptance for Priority Review of Tisotumab Vedotin Biologics License Application for Patients with Recurrent or Metastatic Cervical Cancer

COPENHAGEN, Denmark and BOTHELL, Wash.; April 09, 2021 – Genmab A/S (Nasdaq: GMAB) and Seagen Inc. (Nasdaq: SGEN) today announced that the U.S. Food and...

New England Journal of Medicine Publishes Phase 2b Clinical Trial Results Demonstrating Efficacy of Novavax COVID-19 Vaccine Against the B.1.351 Variant

Publication of initial primary analysis highlights NVX-CoV2373 cross-protection against B.1.351 variant prevalent in South Africa during...

Novavax Initiates Pediatric Expansion for Phase 3 Clinical Trial of COVID-19 Vaccine

PREVENT-19 clinical trial expanded to assess the efficacy, safety and immunogenicity of NVX-CoV2373 for the prevention of COVID-19 in up to 3,000...

Moderna Announces Emergency Use Listing Granted by the World Health Organization for its COVID-19 Vaccine

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr. 30, 2021-- Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and...

Phathom Pharmaceuticals Announces Positive Topline Results from Pivotal Phase 3 Trial of Vonoprazan in Helicobacter pylori (H. pylori) Infection; Study Met All Primary and Secondary Endpoints

Both vonoprazan-based treatment regimens demonstrated superior eradication rates vs. a standard of care proton pump inhibitor (PPI)-based triple therapy New...

New England Journal of Medicine Publishes Results of Global Phase 3 Clinical Program of Vadadustat for the Treatment of Anemia Due to Chronic Kidney Disease

CAMBRIDGE, Mass., April 28, 2021 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of...

Browse by News Type

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.